General 31 May 2026 Daily Monitor (Uganda)
Experimental cancer drug shows promise in early study
Response rates were higher in prostate cancer patients who had not received Pluvicto. Source: https://www.monitor.co.ug/uganda/magazines/healthy-living/experimental-cancer-drug-shows-promise-in-early-study-5479824
Response rates were higher in prostate cancer patients who had not received Pluvicto. Source: https://www.monitor.co.ug/uganda/magazines/healthy-living/experimental-cancer-drug-shows-promise-in-early-study-5479824